Newsmax (NYSE:NMAX) Reaches New 52-Week Low – Time to Sell?

Newsmax shares tumbled to a 52-week low on Friday, trading as low as $7.35 and last at $7.4850 on volume of 53,792 shares. The company reported quarterly EPS of ($0.03), beating the consensus ($0.12) by $0.09, and revenue of $45.27 million (+4% year-over-year), but still shows a deeply negative net margin (−55.99%) and ROE (−255.61%); it has set FY2025 guidance at EPS. Analyst coverage is mixed—two Buys, one Hold and one Sell—with an average “Hold” rating and a $21.50 average price target, and several institutional investors initiated modest positions in Q2, highlighting investor interest despite weak profitability and a pronounced share-price decline.

Analysis

Newsmax shares dropped to a 52-week low, trading as low as $7.35 and last at $7.4850 on volume of 53,792 shares, with the stock noted as trading down about 1.0% on the report day. Analyst coverage is mixed: two Buy, one Hold and one Sell, with recent notes ranging from Weiss Ratings' “sell (d-)” to Noble Financial’s “outperform” and a MarketBeat average price target of $21.50, highlighting divergent expectations among sell‑side firms.

The company reported quarterly EPS of ($0.03), beating consensus of ($0.12) by $0.09, and revenue of $45.27 million, up 4.0% year‑over‑year. Despite the beat, Newsmax continues to show severe profitability strains with a negative net margin of 55.99% and a negative return on equity of 255.61%, and guidance is limited to FY2025 EPS without granular targets.

Institutional activity shows modest new stakes in Q2 from multiple firms (e.g., Stephens Inc. ~$749k, Rovin Capital ~$605k, Wealth Enhancement ~$491k among others), indicating selective interest despite weak fundamentals. Given the 52‑week low, EPS beat and persistent large losses, the near‑term re‑rating catalyst is likely operational margin recovery or materially clearer profitable guidance rather than a single quarterly EPS beat.

Key Decisions for Investors

• Avoid initiating meaningful long positions until the company demonstrates sequential margin improvement or provides concrete FY2025 guidance, given the -55.99% net margin and -255.61% ROE
• If taking exposure, limit position size and treat as speculative—use tight risk controls keyed to the recent 52‑week low of $7.35 as a downside reference
• Monitor the next quarterly report for signs of sustained revenue growth, narrowing losses and cash‑flow improvement; a confirmed turnaround would justify reassessing the consensus $21.50 average price target
• Track institutional flows closely—continued modest accumulation could indicate selective conviction, while further downgrades or share price weakness would heighten downside risk